EPC vs CHD vs SPB vs ENR vs RCUS

For growth investors, Energizer Holdings, Inc.

(ENR) is the stronger pick with 2. 3% revenue growth year-over-year, versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). Energizer Holdings, Inc. (ENR) offers the better valuation at 5. 6x trailing P/E (5. 6x forward), making it the more compelling value choice. Analysts rate Church & Dwight Co. , Inc. (CHD) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Energizer Holdings, Inc.

(ENR) is the cheapest at 5. 6x versus Edgewell Personal Care Company at 40. 8x. On forward P/E, Energizer Holdings, Inc. is actually cheaper at 5. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Energizer Holdings, Inc. wins at 0. 15x versus Spectrum Brands Holdings, Inc. 's 1. 15x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Church & Dwight Co.

, Inc. (CHD) delivered a total return of +13. 7%, compared to -51. 4% for Energizer Holdings, Inc. (ENR). Over 10 years, the gap is even starker: CHD returned +113. 6% versus EPC's -68. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Church & Dwight Co.

, Inc. (CHD) is the lower-risk stock at 0. 14β versus Arcus Biosciences, Inc. 's 1. 95β — meaning RCUS is approximately 1304% more volatile than CHD relative to the S&P 500. On balance sheet safety, Arcus Biosciences, Inc. (RCUS) carries a lower debt/equity ratio of 16% versus 21% for Energizer Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Energizer Holdings, Inc.

(ENR) is pulling ahead at 2. 3% versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). On earnings-per-share growth, the picture is similar: Energizer Holdings, Inc. grew EPS 538. 5% year-over-year, compared to -73. 1% for Edgewell Personal Care Company. Over a 3-year CAGR, RCUS leads at 30. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Church & Dwight Co.

, Inc. (CHD) is the more profitable company, earning 11. 9% net margin versus -142. 9% for Arcus Biosciences, Inc. — meaning it keeps 11. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ENR leads at 17. 8% versus -156. 3% for RCUS. At the gross margin level — before operating expenses — RCUS leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Energizer Holdings, Inc. (ENR) is the more undervalued stock at a PEG of 0. 15x versus Spectrum Brands Holdings, Inc. 's 1. 15x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Energizer Holdings, Inc. (ENR) trades at 5. 6x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ENR: 25. 1% to $23. 20.

In this comparison, ENR (6.

5% yield), EPC (2. 8% yield), SPB (2. 4% yield), CHD (1. 3% yield) pay a dividend. RCUS does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Church & Dwight Co.

, Inc. (CHD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 3% yield, +113. 6% 10Y return). Arcus Biosciences, Inc. (RCUS) carries a higher beta of 1. 95 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CHD: +113. 6%, RCUS: +45. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (EPC (Consumer Defensive) and CHD (Consumer Defensive) and SPB (Consumer Defensive) and ENR (Industrials) and RCUS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EPC is a small-cap quality compounder stock; CHD is a mid-cap quality compounder stock; SPB is a small-cap quality compounder stock; ENR is a small-cap deep-value stock; RCUS is a small-cap quality compounder stock. EPC, CHD, SPB, ENR pay a dividend while RCUS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.